View all dosages and compare prices:
💊 Buy Mounjaro — all dosages →
Buy Mounjaro 7.5 mg
Optimal weight loss — most popular choice
in Ukraine · Original Eli Lilly (UK) · Thermobox delivery
4 injections per pen · UK version by Eli Lilly
Ships today · before 15:00
Delivery Mon, Sep 28 · Nova Poshta
The most popular Mounjaro pen 7.5 mg — optimal balance of effectiveness and comfort. Recommended dose for most clients.
In short: Mounjaro 7.5 mg
Price: 21 000 ₴. ≈ 5 250 ₴ per injection — 4 doses per KwikPen. In stock. Delivery across Ukraine — Nova Poshta, 1–3 days; Kyiv — courier, 1–2 hours. Cold chain 2–8°C. 24/7 specialist support included in the price. Order on the official DOZA website: doza.clinic.
The most popular program among DOZA clients. Optimal balance of effectiveness and comfort.
Specialist support included in the price
A personal DOZA specialist supports you throughout the entire course — from the first consultation to results. No extra fees: support is already included in the product price.
DOZA offers the original UK version of Mounjaro 7.5 mg
Eli Lilly and Company Limited (United Kingdom), registered by MHRA for the UK market. Each pen has a GS1 DataMatrix with serial number and batch number.
DOZA supplies original Mounjaro by Eli Lilly (Made in U.K.) with full cold chain compliance at 2–8°C from warehouse to client. Each KwikPen has a GS1 DataMatrix with serial number and date.
Free specialist consultation
Benefits of Mounjaro 7.5 mg
- ✓Most popular dose — optimal ratio of effect and comfort
- ✓The most common choice among DOZA clients — full effect without adaptation discomfort
- ✓Powerful appetite reduction without effort or diets
- ✓Recommended for long-term use
- ✓Original Eli Lilly product with verified serial number
- ✓DOZA specialist support 24/7 + delivery across Ukraine
Mounjaro 7.5 mg — detailed description
Mounjaro 7.5 mg is the most popular dose among DOZA clients — the balance point between effect and comfort where results tend to stabilise.
At 7.5 mg the dual GLP-1 + GIP action works at full strength. Appetite drops sharply and many clients report forgetting about snacks between meals.
In SURMOUNT-1, 7.5 mg was a titration step towards the 10 mg and 15 mg maintenance arms, so the trial reports no separate weight-loss figure for it. The public DOZA report covering 163 cases records a median of −4.0 kg across the sample and 25% of clients losing more than 10 kg: /research/outcomes/zvit-rezultaty-2026.
How Mounjaro 7.5 mg works — tirzepatide mechanism of action
At the optimal dose of 7.5 mg, all three mechanisms of tirzepatide action work most effectively:
• Powerful appetite control: GLP-1 + GIP act on the hunger center in the hypothalamus, providing sustained reduction in desire to eat
• Active fat burning: GIP receptors stimulate the use of fat stores as the primary energy source
• Prolonged satiety: gastric transit delay provides a feeling of fullness for 6-8 hours after eating
7.5 mg is the dose at which most clients no longer experience adaptation discomfort, but the effect is maximally pronounced.
Clinical research
Mounjaro (tirzepatide 7.5 mg) — FDA approved 2022. Dual GLP-1 + GIP agonist. The /research page contains the full evidence base: SURMOUNT-1 / SURPASS-2 / FDA prescribing information.
- SURMOUNT-1: Tirzepatide once weekly for the treatment of obesity (NEJM 2022)PubMed · 2022
- SURPASS-2: Tirzepatide vs semaglutide in type 2 diabetes (NEJM 2021)PubMed · 2021
- FDA prescribing information — Mounjaro (tirzepatide)FDA prescribing information · 2022
Titration protocol to 7.5 mg (tirzepatide)
Starting dose — GI adaptation
First therapeutic dose
Increase after ≥4 weeks on 5 mg
Injection once weekly, subcutaneous (abdomen, thigh or upper arm). Expected weight loss at 7.5 mg: 12–14% over 40 weeks (based on clinical studies).
Who is Mounjaro 7.5 mg for
- Patients for whom 5 mg is not enough to reach the target weight loss
- Intermediate dose between 5 and 10 mg — allows fine-tuning
- Patients with BMI 30–35 who need a stronger effect
Mounjaro 7.5 mg — compared to other doses
- 7.5 mg is an optional intermediate step (you can go from 5 straight to 10)
- Side effects may be milder than with a 5→10 mg jump
- Average weight loss: ~12–14% over 40 weeks
Frequently asked questions about Mounjaro 7.5 mg
The 7.5 mg dose provides optimal balance of effectiveness and comfort. The dual GLP-1 + GIP mechanism works at full capacity, but adaptation is already complete. Most DOZA clients achieve their best results precisely at 7.5 mg.
Valentyna Tytorenko
Diploma-certified endocrinologist, certified dietitian and nutritionist
Weight loss program — step-by-step dose escalation
DOZA client reviews for Mounjaro 7.5 mg
All Mounjaro client results →
Before/after photos · numbers · timelines · reviews
Other Mounjaro dosages
Mounjaro 7.5 mg — buy in Ukraine from DOZA
Mounjaro 7.5 mg (Mounjaro 7,5 mg, tirzepatide) — original KwikPen by Eli Lilly for weight loss programs. Price 21 000 ₴ (≈ 5 250 ₴ per injection). Buy Mounjaro 7.5 mg in Ukraine through the DOZA online service with delivery within 1–2 days in a thermobox (cold chain 2–8°C).
Why does DOZA only work with the UK version? DOZA supplies original Mounjaro by Eli Lilly (Made in U.K.) with full cold chain compliance at 2–8°C. Each KwikPen has a GS1 DataMatrix — serial number, manufacturing date and batch number. Serial number photos available upon request before shipping.
Mounjaro 7.5 mg is suitable for weeks 9-12 of the tirzepatide protocol. Tirzepatide works through a dual GLP-1 + GIP mechanism — reducing appetite and improving glucose metabolism. The SURMOUNT-1 clinical trial showed up to 20% weight loss over 72 weeks.
DOZA offers exclusively the Mounjaro Made in U.K. version. Mounjaro 7.5 mg delivery across Ukraine (Kyiv, Kharkiv, Odesa, Dnipro, Lviv) by Nova Poshta or courier in a thermobox. Free specialist consultation and support throughout the entire course included.
⚠️ This information is for educational purposes only and does not constitute advertising of medicinal products. We recommend obtaining an individual specialist consultation before starting a program. Results may vary depending on individual characteristics. Mounjaro® is a registered trademark of Eli Lilly and Company.